Browsing by Author

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
2015Comparison of major-bleeding risk and health care costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban, or warfarinAmin, Alpesh ; Keshishian, A ; Xie, L ; Başer, Onur ; Price, K ; Vo, L ; Singh, P ; Bruno, A ; Mardekian, J ; Tan, W ; Singhal, S ; Patel, C ; Odell, K ; Trocio J. 
2016Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarinAmin, Alpesh ; Keshishian, A ; Xie L ; Başer, Onur ; Price, K ; Vo, L ; Mardekian, J ; Mendoza, M ; Singhal, S ; Patel, C ; Odell, K ; Trocio, J 
2017Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States medicare populationAmin, Alpesh ; Keshishian, A ; Trocio, Jeffrey ; Dina, Oluwaseyi ; Le, Hannah ; Rosenblatt, Lisa ; Liu, Xianchen ; Mardekian, Jack ; Zhang, Qisu ; Başer, Onur ; Lien Vo